Catalent Pharma Solutions has joined The Pharma & Biopharma Outsourcing Association (PBOA) as a sustaining member and Cornell Stamoran, vice president, corporate strategy and government affairs at Catalent has been elected to the PBOA’s board of trustees.

Mr. Stamoran leads Catalent’s strategic planning and market intelligence efforts, as well as supports its government affairs, investor relations, global M&A and technology innovation and acquisition activities. He also serves as a founding director of Catalent’s Applied Drug Delivery Institute. Mr. Stamoran has spent more than 25 years in the healthcare industry, including 23 years in advanced drug and biologic delivery and outsourcing.
 
“Catalent Pharma Solutions is one of the world’s largest development and supply partners in the global pharmaceutical industry and we’re delighted to bring them into the Pharma & Biopharma Outsourcing Association,” said Gil Roth, president of the PBOA. “Cornell Stamoran’s extensive experience and strategic focus will be of great value to our Board as we advance our membership’s legislative, regulatory and business interests.”
 
Mr. Stamoran said, “The outsourcing of drug product manufacturing has expanded significantly since I came to the advanced delivery technologies side of the industry in 1992. Today, outsourcing serves a critical role in ensuring consistent supply of prescription, OTC and consumer health products to our customers, and ultimately to patients. As a result, it is more important than ever for us to advocate for our interests, both legislative and regulatory. I’m pleased to represent Catalent, and to work to advance the Association’s goals.”